Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Medivate Partners
investment firm
About
Medivate Partners LLC is an investment arm of Posco specializing in cross border, growth capital, early stage and mid stage.
- Seoul,Seoul-t'ukpyolsi,South Korea
- http://www.medivatepartners.com
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
5
1
Medivate Partners has made 5 investments. Their most recent investment was on
Jun 26, 2020, when Artiva Biotherapeutics raised $78M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 26, 2020
Artiva Biotherapeutics
|
Series A | $78M | Biotechnology | — |
|
Jan 22, 2020
Cognate BioServices
|
Series B | — | Biotechnology | — |
|
Jun 18, 2018
WindMIL Therapeutics
|
Series B | $32.50M | Biotechnology | — |
|
Feb 20, 2018
Cognate BioServices
|
Series Unknown | — | Biotechnology | — |
|
Mar 21, 2016
SillaJen
|
Series Unknown | $12M | Biotechnology | Yes |
Employee Profiles
Number of Employee Profiles
1
Medivate Partners has 1 current employee profiles, including
Executive Paul Kim
Executive
Exits
Medivate Partners has had 2 exits. Medivate Partners most notable exits include Cognate BioServices , SillaJen
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Feb 17, 2021 | Cognate BioServices | M&A | Biotechnology | Detail |
| Dec 8, 2016 | SillaJen | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
